const e=()=>[{title:"ğŸ“– Management Summary",points:["**TAB_START:Summary**","## <u>**Pneumonia in Pregnancy - Management Protocol**</u>","","### <u>**1. Diagnosis & Assessment**</u>","â€¢ **Clinical Suspicion**: Fever, cough, dyspnea, chest pain in pregnancy","â€¢ **Safe Imaging**: Chest X-ray with abdominal shielding, CT if needed","â€¢ **Laboratory**: Complete blood count, inflammatory markers, blood cultures","â€¢ **Oxygen Saturation**: Pulse oximetry, arterial blood gas if hypoxic","","### <u>**2. Treatment Protocol**</u>","â€¢ **Outpatient**: Amoxicillin or azithromycin for mild community-acquired pneumonia","â€¢ **Inpatient**: IV ampicillin + azithromycin for moderate-severe cases","â€¢ **Severe/ICU**: Broad-spectrum antibiotics, mechanical ventilation if needed","â€¢ **Avoid**: Fluoroquinolones, doxycycline, clarithromycin in pregnancy","","### <u>**3. Maternal-Fetal Monitoring**</u>","â€¢ **Oxygen Therapy**: Maintain SaOâ‚‚ >95%, continuous monitoring","â€¢ **Fetal Assessment**: CTG monitoring, ultrasound for growth","â€¢ **Complications**: ARDS, sepsis, preterm labor surveillance","â€¢ **Vaccination**: Pneumococcal vaccine postpartum, influenza annually","","---","","**âš ï¸ Key Management Points:**","â€¢ Early recognition and treatment prevent maternal and fetal complications","â€¢ Pregnancy increases risk of severe pneumonia and complications","â€¢ Most antibiotics safe in pregnancy - avoid teratogenic agents","**TAB_END**"]},{title:"ğŸ« Pneumonia in Pregnancy - Comprehensive Clinical Overview",points:["ğŸ« **Definition**: Pneumonia in pregnancy is acute infection of lung parenchyma caused by bacteria, viruses, or atypical organisms, characterized by fever, respiratory symptoms, and radiographic infiltrates. Pregnancy-associated immunosuppression and physiological changes increase susceptibility to severe disease, complications, and adverse maternal-fetal outcomes","ğŸ“Š **Incidence**: 1-4 per 1000 pregnancies, leading non-obstetric cause of maternal mortality","ğŸ’€ **Maternal Mortality**: 3-17% in severe cases, higher with viral pneumonia","ğŸ¤° **Pregnancy Risk**: 3-4 fold increased risk compared to non-pregnant women","ğŸ¦  **Common Pathogens**: Streptococcus pneumoniae, Haemophilus influenzae, atypical organisms","âš¡ **Complications**: ARDS, sepsis, preterm labor, fetal hypoxia","ğŸ“ˆ **Seasonal Pattern**: Higher incidence during influenza season, winter months","ğŸ¥ **Hospitalization**: 90% require inpatient management vs 20% non-pregnant"]},{title:"ğŸ“Š Pneumonia Epidemiology - Global & Kenya Context",subsections:[{title:"ğŸŒ Global Pneumonia in Pregnancy",points:["ğŸ“ˆ **Global Incidence**: 1-4 per 1000 pregnancies worldwide","ğŸ’€ **Mortality Rates**: 3-17% maternal mortality, higher in developing countries","ğŸ¦  **Pathogen Distribution**: S. pneumoniae (40%), H. influenzae (20%), atypical (30%)","ğŸŒ¡ï¸ **Seasonal Variation**: 2-3 fold increase during winter months, influenza season","ğŸ“Š **Severity**: 25-30% develop severe pneumonia requiring ICU care","ğŸ¤° **Gestational Age**: Higher risk in third trimester, postpartum period","ğŸ’Š **Vaccination Impact**: 50-70% reduction with pneumococcal vaccination","ğŸ“ˆ **Rising Incidence**: Increasing due to H1N1, COVID-19 pandemics"]},{title:"ğŸ‡°ğŸ‡ª Kenya Pneumonia Profile",points:["ğŸ“Š **National Burden**: 15-25 per 1000 pregnancies, higher than global average","ğŸ’€ **Maternal Mortality**: 8-12% case fatality rate","ğŸ¦  **Common Pathogens**: S. pneumoniae, H. influenzae, tuberculosis, viral","ğŸ¥ **Healthcare Access**: Delayed presentation, limited ICU facilities","ğŸŒ§ï¸ **Seasonal Pattern**: Peaks during rainy seasons, cold months","ğŸ’‰ **Vaccination Coverage**: Low pneumococcal vaccination rates","ğŸ¦  **HIV Co-infection**: 15-25% in high-prevalence areas","ğŸ“ˆ **Risk Factors**: Malnutrition, indoor air pollution, biomass fuels"]},{title:"ğŸ”ï¸ Nakuru County Specific Profile",points:["ğŸ“ **Geographic Risk**: Highland climate, temperature variations","ğŸŒ¡ï¸ **Seasonal Pattern**: Higher incidence June-August (cold season)","ğŸ¥ **Healthcare Infrastructure**: Referral hospital, district facilities","ğŸ‘¥ **Population Risk**: Urban air pollution, rural biomass exposure","ğŸ“Š **Disease Burden**: 800-1200 cases annually in pregnant women","ğŸ’‰ **Prevention**: Limited pneumococcal vaccine availability","ğŸ  **Housing**: Poor ventilation, overcrowding increase risk","ğŸ“ˆ **Trend**: Increasing incidence with urbanization"]}]},{title:"ğŸ”¬ Pathogenesis of Pneumonia in Pregnancy",subsections:[{title:"ğŸ¦  Microbial Pathogenesis",points:["ğŸ« **Bacterial Invasion**: Aspiration, hematogenous spread, direct extension","ğŸ›¡ï¸ **Host Defense Breach**: Mucociliary clearance impairment, alveolar macrophage dysfunction","ğŸ”¥ **Inflammatory Response**: Neutrophil recruitment, cytokine release, capillary leak","ğŸ’§ **Alveolar Flooding**: Protein-rich exudate, impaired gas exchange","ğŸ©¸ **Systemic Effects**: Bacteremia, sepsis syndrome, multi-organ dysfunction","âš¡ **Tissue Damage**: Direct bacterial toxins, inflammatory mediators","ğŸ”„ **Resolution**: Bacterial clearance, inflammation resolution, tissue repair","ğŸ’€ **Complications**: Abscess formation, empyema, necrotizing pneumonia"]},{title:"ğŸ¤° Pregnancy-Specific Pathophysiology",points:["ğŸ›¡ï¸ **Immune Suppression**: Th1â†’Th2 shift, reduced cell-mediated immunity","ğŸ« **Respiratory Changes**: Reduced functional residual capacity, elevated diaphragm","ğŸ’“ **Cardiovascular**: Increased cardiac output, reduced systemic vascular resistance","ğŸŒŠ **Fluid Dynamics**: Increased blood volume, reduced oncotic pressure","ğŸ”¥ **Inflammatory Response**: Enhanced cytokine production, systemic effects","âš¡ **Oxygen Demand**: Increased consumption, reduced reserve capacity","ğŸ§¬ **Placental Effects**: Reduced perfusion, inflammatory mediator transfer","ğŸ“ˆ **Progression Risk**: Faster deterioration, higher complication rates"]}]},{title:"âš”ï¸ Effects of Pregnancy on Pneumonia Susceptibility",subsections:[{title:"ğŸ›¡ï¸ Immunological Changes",points:["ğŸ“‰ **Cell-Mediated Immunity**: Reduced T-helper 1 response, impaired bacterial clearance","ğŸ”„ **Cytokine Profile**: Anti-inflammatory bias, reduced interferon-Î³ production","ğŸ½ï¸ **Alveolar Macrophages**: Reduced phagocytic function, impaired bacterial killing","âš¡ **Neutrophil Function**: Delayed recruitment, reduced antimicrobial activity","ğŸ§¬ **Complement System**: Reduced complement activation, impaired opsonization","ğŸ’€ **Natural Killer Cells**: Suppressed activity, reduced viral clearance","ğŸ¯ **Antibody Response**: Altered humoral immunity, reduced vaccine efficacy","ğŸ”¥ **Inflammatory Resolution**: Delayed resolution, prolonged illness"]},{title:"ğŸ« Respiratory Physiology Changes",points:["ğŸ“‰ **Functional Residual Capacity**: 20% reduction, rapid desaturation","ğŸ’¨ **Tidal Volume**: 40% increase, respiratory alkalosis","âš¡ **Oxygen Consumption**: 20% increase, reduced reserve","ğŸ« **Chest Wall Compliance**: Reduced due to enlarged uterus","ğŸ’§ **Mucociliary Clearance**: Impaired clearance, retained secretions","ğŸŒŠ **Pulmonary Edema Risk**: Increased due to fluid retention","ğŸ“ˆ **Work of Breathing**: Increased effort, early fatigue","ğŸ¯ **Gas Exchange**: V/Q mismatch, arterial-alveolar gradient increase"]}]},{title:"ğŸ¤° Effects of Pneumonia on Pregnancy",subsections:[{title:"ğŸ©¸ Maternal Complications",points:["ğŸ« **Respiratory Failure**: ARDS development in 15-25% severe cases","ğŸ’€ **Sepsis Syndrome**: Systemic inflammatory response, organ dysfunction","ğŸ’“ **Cardiovascular**: Hypotension, cardiac failure, arrhythmias","ğŸ§  **Neurological**: Hypoxic encephalopathy, altered consciousness","ğŸ«˜ **Renal**: Acute kidney injury, prerenal azotemia","ğŸ”¥ **Hematological**: DIC, thrombocytopenia, anemia","ğŸ’§ **Metabolic**: Acidosis, electrolyte imbalance, hyperglycemia","ğŸ¤° **Obstetric**: Preterm labor, cervical changes, membrane rupture"]},{title:"ğŸ‘¶ Fetal Effects",points:["âš–ï¸ **Growth Restriction**: Chronic hypoxia, reduced nutrient transfer","â° **Preterm Birth**: 25-40% incidence, inflammatory mediators","ğŸ’€ **Fetal Demise**: Severe maternal hypoxia, placental insufficiency","ğŸ§  **Neurological**: Hypoxic brain injury, developmental delays","ğŸ« **Pulmonary**: Delayed lung maturity, respiratory distress","ğŸ“ **Birth Weight**: Mean reduction 300-500g","ğŸ’“ **Cardiovascular**: Fetal hypoxia, bradycardia episodes","ğŸ“ˆ **Long-term**: Increased childhood respiratory infections"]}]},{title:"ğŸ©º Clinical Presentation - Comprehensive Assessment",subsections:[{title:"ğŸŒ¡ï¸ Classic Pneumonia Symptoms",points:["ğŸ”¥ **Fever**: >38Â°C, may be blunted in pregnancy","ğŸ˜· **Cough**: Initially dry, becomes productive with purulent sputum","ğŸ« **Chest Pain**: Pleuritic pain, sharp, worse with inspiration","ğŸ’¨ **Dyspnea**: Progressive breathlessness, exercise intolerance","ğŸ˜° **Chills/Rigors**: Uncontrollable shaking, teeth chattering","ğŸ’ª **Myalgia**: Generalized body aches, fatigue","ğŸ¤¢ **Gastrointestinal**: Nausea, vomiting, diarrhea","ğŸ§  **Neurological**: Headache, confusion, altered mental status"]},{title:"ğŸ¤° Pregnancy-Modified Presentations",points:["ğŸ« **Respiratory**: Earlier dyspnea due to physiological changes","ğŸ’“ **Cardiovascular**: Tachycardia may be normal pregnancy finding","ğŸŒ¡ï¸ **Temperature**: Fever may be lower grade or absent","ğŸ’§ **Hydration**: Rapid dehydration, electrolyte imbalance","ğŸ¤° **Obstetric**: Uterine contractions, cervical changes","ğŸ˜´ **Fatigue**: More pronounced than normal pregnancy tiredness","ğŸ½ï¸ **Appetite**: Severe anorexia, weight loss","âš¡ **Rapid Deterioration**: Faster progression to severe disease"]},{title:"âš ï¸ Severe Disease Manifestations",points:["ğŸ« **Respiratory Distress**: Accessory muscle use, cyanosis","ğŸ’€ **Altered Consciousness**: Confusion, stupor, coma","ğŸ’“ **Shock**: Hypotension, poor perfusion, oliguria","ğŸŒŠ **Pulmonary Edema**: Bilateral crackles, pink frothy sputum","ğŸ¤° **Fetal Distress**: Bradycardia, reduced movements","ğŸ”¥ **Sepsis**: Temperature instability, leukocytosis/leukopenia","ğŸ’§ **Organ Dysfunction**: Multi-organ failure signs","âš¡ **Critical Illness**: ICU admission criteria met"]}]},{title:"ğŸ” Examination Findings",subsections:[{title:"ğŸŒ¡ï¸ Vital Signs Assessment",points:["ğŸŒ¡ï¸ **Temperature**: Fever >38Â°C, hypothermia in severe sepsis","ğŸ’“ **Heart Rate**: Tachycardia >100bpm, weak pulse quality","ğŸ« **Respiratory Rate**: Tachypnea >24/min, shallow breathing","ğŸ©¸ **Blood Pressure**: Normal early, hypotension in shock","ğŸ“Š **Oxygen Saturation**: <95% concerning, <92% severe","ğŸ§  **Mental Status**: Alert to obtunded, GCS assessment","âš–ï¸ **Weight**: Acute weight loss, dehydration","ğŸ’§ **Perfusion**: Capillary refill, skin color, temperature"]},{title:"ğŸ« Respiratory Examination",points:["ğŸ‘€ **Inspection**: Accessory muscle use, chest wall movement asymmetry","ğŸ«³ **Palpation**: Reduced expansion, tactile fremitus changes","ğŸ¥ **Percussion**: Dullness over consolidation areas","ğŸ‘‚ **Auscultation**: Bronchial breathing, coarse crackles, pleural friction rub","ğŸ—£ï¸ **Voice Sounds**: Bronchophony, egophony, whispered pectoriloquy","ğŸ’¨ **Breathing Pattern**: Shallow, rapid, use of accessory muscles","ğŸ”Š **Adventitious Sounds**: Wheeze, rhonchi, absent breath sounds","ğŸŒŠ **Signs of Effusion**: Stony dullness, absent breath sounds"]},{title:"ğŸ¤° Obstetric Assessment",points:["ğŸ“ **Fundal Height**: Appropriate for gestational age","ğŸ‘‚ **Fetal Heart Rate**: Continuous monitoring if >24 weeks","ğŸ”„ **Fetal Movement**: Reduced activity concerning","ğŸ’“ **Uterine Activity**: Contractions, cervical assessment","ğŸŒŠ **Amniotic Fluid**: Oligohydramnios assessment","ğŸ©¸ **Vaginal Examination**: Bleeding, membrane status","âš–ï¸ **Estimated Fetal Weight**: Growth assessment","ğŸ“Š **Biophysical Profile**: If indicated for fetal well-being"]}]},{title:"ğŸ”¬ Comprehensive Investigations",subsections:[{title:"ğŸ–¼ï¸ Imaging Studies",points:["ğŸ“¸ **Chest X-ray**: PA and lateral, abdominal shielding, 95% sensitivity","ğŸ« **CT Chest**: High-resolution CT for complications, empyema","ğŸ«€ **Echocardiogram**: Cardiac function, pulmonary hypertension","ğŸ‘¶ **Obstetric Ultrasound**: Fetal well-being, growth assessment","ğŸ“± **Point-of-Care**: Bedside lung ultrasound, B-lines detection","ğŸ¦´ **Other Imaging**: Abdominal CT if indicated for complications"]},{title:"ğŸ©¸ Laboratory Tests",points:["ğŸ“Š **Complete Blood Count**: Leukocytosis, left shift, thrombocytopenia","ğŸ”¥ **Inflammatory Markers**: CRP >100mg/L, procalcitonin elevation","ğŸ§ª **Blood Chemistry**: Electrolytes, glucose, liver function, renal function","ğŸ’¨ **Arterial Blood Gas**: Hypoxemia, acid-base status","ğŸ©¸ **Blood Cultures**: Before antibiotics, 2 sets from different sites","ğŸ¦  **Sputum Culture**: If productive cough, Gram stain","ğŸ§¬ **Viral Testing**: Influenza, RSV, COVID-19 PCR","ğŸ’‰ **Pneumococcal Antigen**: Urine antigen test"]},{title:"ğŸ”¬ Specialized Tests",points:["ğŸ¦  **Atypical Pathogens**: Mycoplasma, Chlamydia, Legionella serology","ğŸ§¬ **Molecular Diagnostics**: Multiplex PCR panels","ğŸ’§ **Pleural Fluid**: If effusion present, pleural tap","ğŸ”¬ **Bronchoscopy**: If immunocompromised or not responding","ğŸ¯ **Biomarkers**: Procalcitonin, lactate for severity","ğŸ§ª **Coagulation**: PT/PTT, D-dimer if DIC suspected","ğŸ“Š **Severity Scores**: CURB-65, pneumonia severity index","ğŸ¦  **TB Screening**: If risk factors present, GeneXpert"]}]},{title:"ğŸ’Š Comprehensive Treatment Protocols",subsections:[{title:"ğŸ  Outpatient Treatment (Mild CAP)",points:["ğŸ’Š **First-Line: Amoxicillin**","  â€¢ Dosing: 1g three times daily for 5-7 days","  â€¢ Safe in pregnancy, excellent pneumococcal coverage","  â€¢ Alternative: Amoxicillin-clavulanate 875/125mg BID","","ğŸŒ¿ **Macrolides (if atypical suspected)**","  â€¢ Azithromycin: 500mg day 1, then 250mg daily Ã— 4 days","  â€¢ Erythromycin: 500mg QID Ã— 7 days","  â€¢ Avoid clarithromycin in pregnancy","","ğŸ“Š **Monitoring**","  â€¢ 48-72 hour follow-up, clinical improvement","  â€¢ Return if worsening symptoms, fever persistence","  â€¢ Fetal movement monitoring if >24 weeks"]},{title:"ğŸ¥ Inpatient Treatment (Moderate-Severe)",points:["ğŸ’‰ **IV Therapy**","  â€¢ Ampicillin: 2g IV q6h + Azithromycin 500mg IV daily","  â€¢ Alternative: Ceftriaxone 2g IV daily + Azithromycin","  â€¢ Severe: Add vancomycin if MRSA risk","","ğŸ« **Respiratory Support**","  â€¢ Oxygen therapy: Target SaOâ‚‚ >95%","  â€¢ High-flow nasal cannula if needed","  â€¢ Non-invasive ventilation consideration","","ğŸ¥ **Supportive Care**","  â€¢ IV fluids: Balanced crystalloids, avoid overload","  â€¢ Antipyretics: Paracetamol safe in pregnancy","  â€¢ DVT prophylaxis: LMWH unless contraindicated"]},{title:"ğŸš¨ ICU Management (Severe/Critical)",points:["ğŸ’‰ **Broad-Spectrum Antibiotics**","  â€¢ Piperacillin-tazobactam + vancomycin + azithromycin","  â€¢ Consider antifungal if immunocompromised","  â€¢ Adjust based on cultures and sensitivity","","ğŸ« **Mechanical Ventilation**","  â€¢ Lung-protective strategies: TV 6-8ml/kg","  â€¢ PEEP optimization, avoid hyperoxia","  â€¢ Prone positioning if severe ARDS","","ğŸ’“ **Hemodynamic Support**","  â€¢ Norepinephrine first-line vasopressor","  â€¢ Target MAP >65mmHg","  â€¢ Central venous access, arterial monitoring"]}]},{title:"âš ï¸ Maternal Complications",subsections:[{title:"ğŸ« Respiratory Complications",points:["ğŸ’§ **ARDS**: 15-25% of severe pneumonia, 30-50% mortality","ğŸŒŠ **Pulmonary Edema**: Cardiogenic and non-cardiogenic causes","ğŸ’¨ **Respiratory Failure**: Type I (hypoxemic) most common","ğŸ•³ï¸ **Pneumothorax**: Barotrauma from mechanical ventilation","ğŸ”¥ **Empyema**: Complicated parapneumonic effusion","ğŸ’€ **Lung Abscess**: Necrotizing pneumonia complications","ğŸ« **Bronchiectasis**: Long-term structural damage","âš¡ **Ventilator-Associated**: Pneumonia, lung injury"]},{title:"ğŸ’€ Systemic Complications",points:["ğŸ”¥ **Sepsis/Septic Shock**: Multi-organ dysfunction","ğŸ’“ **Cardiovascular**: Myocarditis, pericarditis, arrhythmias","ğŸ§  **Neurological**: Encephalopathy, stroke, seizures","ğŸ«˜ **Renal**: Acute kidney injury, dialysis requirement","ğŸ©¸ **Hematological**: DIC, thrombocytopenia, anemia","ğŸ’§ **Metabolic**: Acidosis, electrolyte imbalance","ğŸ½ï¸ **Gastrointestinal**: Ileus, stress ulceration","ğŸ¦´ **Musculoskeletal**: ICU-acquired weakness"]}]},{title:"ğŸ‘¶ Fetal & Neonatal Effects",subsections:[{title:"ğŸ¤° Immediate Fetal Effects",points:["â° **Preterm Labor**: 25-40% incidence, inflammatory mediators","ğŸ’€ **Fetal Demise**: Severe maternal hypoxia, acidosis","ğŸ“ **Growth Restriction**: Chronic hypoxia, placental insufficiency","ğŸ§  **Hypoxic Injury**: Brain damage, developmental delays","ğŸ’“ **Fetal Distress**: Bradycardia, reduced variability","ğŸŒŠ **Oligohydramnios**: Reduced amniotic fluid","ğŸ©¸ **Placental Abruption**: Hypoxia-induced complications","âš–ï¸ **Low Birth Weight**: Mean reduction 300-500g"]},{title:"ğŸ‘¶ Neonatal Complications",points:["ğŸ« **Respiratory Distress**: Prematurity, maternal illness","ğŸ§  **Neurological**: Hypoxic-ischemic encephalopathy","ğŸ’“ **Cardiovascular**: Persistent pulmonary hypertension","ğŸ¦  **Infections**: Increased susceptibility, sepsis risk","ğŸ“ˆ **Growth**: Failure to thrive, feeding difficulties","ğŸ‘ï¸ **Developmental**: Long-term neurodevelopmental delays","ğŸ« **Chronic Lung**: Bronchopulmonary dysplasia risk","ğŸ“Š **Mortality**: 2-3 fold increased neonatal death rate"]}]},{title:"ğŸ›¡ï¸ Prevention Strategies",subsections:[{title:"ğŸ’‰ Vaccination Programs",points:["ğŸ¦  **Pneumococcal Vaccine**: PCV13/PPSV23 before/after pregnancy","ğŸŒ¡ï¸ **Influenza Vaccine**: Annual vaccination during pregnancy","ğŸ¤± **Tdap**: Whooping cough prevention, third trimester","ğŸ« **COVID-19**: mRNA vaccines safe and effective in pregnancy","ğŸ“… **Timing**: Influenza anytime during pregnancy","ğŸ¯ **High-Risk**: Prioritize women with comorbidities","ğŸ‘¶ **Maternal**: Passive immunity transfer to newborn","ğŸŒ **Community**: Herd immunity benefits"]},{title:"ğŸ  Environmental & Lifestyle",points:["ğŸš¬ **Smoking Cessation**: Major modifiable risk factor","ğŸ  **Indoor Air Quality**: Reduce biomass fuel exposure","ğŸ¤ **Hand Hygiene**: Frequent handwashing, alcohol rubs","ğŸ˜· **Mask Wearing**: During respiratory illness outbreaks","ğŸ‘¥ **Avoid Crowds**: During epidemic periods","ğŸ½ï¸ **Nutrition**: Adequate protein, vitamin supplementation","ğŸ’ª **Exercise**: Moderate exercise, immune function","ğŸ˜´ **Sleep**: Adequate rest, stress management"]}]},{title:"ğŸ‡°ğŸ‡ª Kenya-Specific Considerations",points:["ğŸ¥ **Healthcare Access**: Limited ICU facilities, delayed presentation","ğŸ’‰ **Vaccination**: Low pneumococcal vaccine coverage","ğŸ¦  **HIV Co-infection**: 15-25% in high-prevalence areas","ğŸ  **Indoor Air Pollution**: Biomass fuels, poor ventilation","ğŸ½ï¸ **Malnutrition**: Protein-energy deficiency common","ğŸŒ§ï¸ **Seasonal**: Rainy season outbreaks, cold highlands","ğŸ’° **Socioeconomic**: Poverty, limited healthcare access","ğŸ˜ï¸ **Urban Slums**: Overcrowding, poor sanitation","ğŸ“± **mHealth**: Mobile health platforms for education","ğŸ¤ **Community**: Traditional healers, health education"]}];export{e as getPneumoniaPregnancyContent};
